250 Participants Needed

CBT + Low FODMAP Diet for IBS

Recruiting at 1 trial location
RJ
CA
Overseen ByCynthia A. Boutte, BSN
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Baylor College of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is find out if we can use simple tests (biomarkers) to tell us if a specific child would benefit most from CBT or from the low FODMAPs diet.

Who Is on the Research Team?

RJ

Robert J. Shulman, MD

Principal Investigator

Baylor College of Medicine

RL

Rona Levy, PhD

Principal Investigator

University of Washington

Are You a Good Fit for This Trial?

This trial is for children aged 7-12 with functional gastrointestinal disorders like IBS, who experience abdominal pain without an organic cause. They must understand English due to the nature of assessments and treatments involved. Kids with past bowel surgery, chronic diseases like Crohn's or diabetes, developmental disorders, or those already on FODMAP diets or CBT are excluded.

Inclusion Criteria

Parents and children must speak and understand English because of the psychological assessment and CBT requirements
My child is 7-12 years old with stomach pain not caused by a physical illness.

Exclusion Criteria

My child has had surgery on their intestines before.
Kids who cannot be chosen at random to follow the low FODMAP diet for some reason.
My child follows a vegetarian diet.
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Children are randomized to receive either Cognitive Behavioral Therapy or a low FODMAP diet for a 3-week treatment period

3 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Cognitive Behavioral Therapy
  • Low FODMAP Diet
Trial Overview The study aims to determine if certain biomarkers can predict whether a child would benefit more from Cognitive Behavioral Therapy (CBT) or a Low FODMAP Diet for managing symptoms of pediatric chronic pain associated with gastrointestinal issues.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Low FODMAP dietExperimental Treatment1 Intervention
Low FODMAP diet
Group II: Cognitive Behavioral TherapyExperimental Treatment1 Intervention
Cognitive Behavioral Therapy

Cognitive Behavioral Therapy is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Cognitive Behavioral Therapy for:
  • Anxiety disorders
  • Depressive disorders
  • Eating disorders
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)
🇺🇸
Approved in United States as Cognitive Behavioral Therapy for:
  • Anxiety disorders
  • Depressive disorders
  • Eating disorders
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)
  • Substance use disorders
🇨🇦
Approved in Canada as Cognitive Behavioral Therapy for:
  • Anxiety disorders
  • Depressive disorders
  • Eating disorders
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)

Find a Clinic Near You

Who Is Running the Clinical Trial?

Baylor College of Medicine

Lead Sponsor

Trials
1,044
Recruited
6,031,000+

University of Washington

Collaborator

Trials
1,858
Recruited
2,023,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security